With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

Suzhou-based Innovent Biologics secured approval last week for its treatment mazdutide. Read more at straitstimes.com. Read ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...

Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...

For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”) ...

making it a competitor to Amazon, which runs a pharmacy division that offers same-day drug delivery in some locations. It has also partnered with Eli Lilly to sell weight loss drugs directly to ...

The weight loss and diabetes drug Wegovy (also known as Ozempic) which is only available on prescription, should be on pharmacy shelves as of 1 July, drug maker Novo Nordisk confirmed. It ends a years ...

Oresund bridge is a mega-engineering project comprising a combined rail and road bridge and tunnel connecting Sweden and ...